Garcia-Borreguero says the drug was generally "well-tolerated." "We still need to do a large, multi-center, well-controlled study that confirms these," says Rajesh Pahwa, M.D., director of the Parkinson Disease and Movement Disorder Center at the University of Kansas Medical Center
The lack of head-to-head trials comparing tirzepatide monotherapy versus tirzepatide plus phentermine means there is no definitive evidence that combination therapy offers superior outcomes or acceptable safety profiles
No membership fees, no subscription, no hidden costs
Simulations of SNAC and CTAB were performed as follows: First, a CTAB micelle structure was generated by randomly inserting 25 molecules of CTAB (50 mM) into a periodic boundary box, which was then solvated and equilibrated for 100 ns
When it comes to agricultural research being done in developing countries, Quesada-Ocampo says extension is key